Cargando…

Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies

CONTEXT: The phosphate-regulating hormone fibroblast growth factor 23 (FGF23) has been linked to deregulations in glucose metabolism, but its role is insufficiently understood. OBJECTIVE: This study investigates potential crosstalk between FGF23 and glucose homeostasis. METHODS: First, we investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Vaart, Amarens, Eelderink, Coby, van Beek, André P, Bakker, Stephan J L, van Dijk, Peter R, de Borst, Martin H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505526/ https://www.ncbi.nlm.nih.gov/pubmed/37139691 http://dx.doi.org/10.1210/clinem/dgad246

Ejemplares similares

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Higher betaine is associated with lower incidence of microvascular complications in type 2 diabetes (Zodiac‐61)
por: van der Vaart, Amarens, et al.
Publicado: (2022)

Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Plasma phosphate and all-cause mortality in individuals with and without type 2 diabetes: the Dutch population-based lifelines cohort study
por: van der Vaart, Amarens, et al.
Publicado: (2022)

The Paradoxical Role of Circulating Ketone Bodies in Glycemic Control of Individuals with Type 2 Diabetes: High Risk, High Reward?
por: van der Vaart, Amarens, et al.
Publicado: (2022)

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort
por: Yeung, Stanley M. H., et al.
Publicado: (2021)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
por: Yeung, Stanley M. H., et al.
Publicado: (2020)

Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness: A Randomized, Double‐Blind, Placebo‐Controlled Intervention Trial
por: Schutten, Joëlle C., et al.
Publicado: (2022)

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study
por: Eisenga, Michele F., et al.
Publicado: (2019)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus
por: Mencke, Rik, et al.
Publicado: (2021)

New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
por: Mace, Maria L., et al.
Publicado: (2020)

Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: De Jong, Maarten A, et al.
Publicado: (2020)

Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study
por: Panwar, Bhupesh, et al.
Publicado: (2016)

Dietary Protein Sources and Muscle Mass over the Life Course: The Lifelines Cohort Study
por: Alexandrov, Nikita V., et al.
Publicado: (2018)

Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification
por: ter Braake, Anique D, et al.
Publicado: (2019)

The effect of high compared with low dairy consumption on glucose metabolism, insulin sensitivity, and metabolic flexibility in overweight adults: a randomized crossover trial
por: Eelderink, Coby, et al.
Publicado: (2019)

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease
por: Vermeulen, Emma A., et al.
Publicado: (2022)

Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis
por: Westerberg, Per-Anton, et al.
Publicado: (2012)

α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent
por: Erben, Reinhold G.
Publicado: (2018)

Functional vitamin K status and risk of incident chronic kidney disease and microalbuminuria: a prospective general population-based cohort study
por: Groothof, Dion, et al.
Publicado: (2020)

Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure
por: van Breda, Fenna, et al.
Publicado: (2015)

Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies
por: Kremer, Daan, et al.
Publicado: (2021)

Reply to Janssen et al. Comment on “Kremer et al. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021, 13, 3069”
por: Kremer, Daan, et al.
Publicado: (2022)

The Serum Level of Fibroblast Growth Factor-23 and Calcium-Phosphate Homeostasis in Obese Perimenopausal Women
por: Holecki, M., et al.
Publicado: (2011)

(Pro)renin Receptor Regulates Phosphate Homeostasis in Rats via Releasing Fibroblast Growth Factor-23
por: Lu, Aihua, et al.
Publicado: (2022)

Epoetin Beta and C‐Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease
por: Eisenga, Michele F., et al.
Publicado: (2019)

Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial
por: de Borst, Martin H., et al.
Publicado: (2017)

Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
por: McGrath, Emer R., et al.
Publicado: (2019)

Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults
por: Paul, Shejuti, et al.
Publicado: (2021)

Acute sub-diaphragmatic anterior vagus nerve stimulation increases peripheral glucose uptake in anaesthetized rats
por: Hoornenborg, C.W., et al.
Publicado: (2023)

Effect of High versus Low Dairy Consumption on the Gut Microbiome: Results of a Randomized, Cross-Over Study
por: Swarte, J. Casper, et al.
Publicado: (2020)

Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy
por: Humalda, Jelmer K., et al.
Publicado: (2016)

Increasing incidence of group B streptococcus neonatal infections in the Netherlands is associated with clonal expansion of CC17 and CC23
por: Jamrozy, Dorota, et al.
Publicado: (2020)

Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
por: Alonso, Alvaro, et al.
Publicado: (2014)

Effect of high compared with low dairy intake on blood pressure in overweight middle-aged adults: results of a randomized crossover intervention study
por: Rietsema, Susan, et al.
Publicado: (2019)

Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice
por: Panaro, Brandon L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f0ru9tm64vi3c4s6p44815lihg